Investors > Corporate Governance
Corporate Information
NASDAQ:OKYO
The names of the directors and biographical details
Please click on the link below for the names and brief biographical details of each director.
Board Diversity
Please click on the link below for details of OKYO Pharma’s Board Diversity.
Directors’ responsibilities
Please click on the link below for details on the directors’ responsibilities.
Board committees
Please click on the link below for details of OKYO Pharma’s Board committees.
Advisers
Please click on the link below for details of OKYO Pharma’s key advisers.
Country of incorporation and main country of operation
OKYO Pharma is incorporated and registered in Guernsey with company number 65220. OKYO Pharma’s main country of operation is the United Kingdom. Please click on the link below for the Memorandum and the Articles of Association.
Company announcements
Please click on the link below to access notifications made by OKYO Pharma in the past 12 months.
Details of any other exchanges or trading platforms
OKYO Pharma is not listed on any other exchanges or trading platforms.
Number of securities in issue
Please click on the link below for details of the number of securities in issue, the number of securities held as treasury shares and, insofar as OKYO Pharma is aware, the percentage of securities that is not in public hands together with the identity and percentage holdings of significant shareholders.
Details of any restrictions on the transfer of securities
There are no restrictions on the transfer of securities.
Financial information
Please click on the link below for access to OKYO Pharma’s annual and interim reports.
Admission documents and circulars
Please click on the appropriate links below to access:
ISIN
Please note that OKYO Pharma’s ISIN number is GG00BMFG5F62 .
CUSIP
Please note that OKYO Pharma’s CUSIP number is G6724L116